IE 11 is not supported. For an optimal experience visit our site on another browser.

Stocks finish down after prior session’s rally

Stocks fell slightly but showed more signs of stability Wednesday as investors sifted through new economic data and found little reason to resume last week’s heavy selling pace.
/ Source: The Associated Press

Stocks fell slightly but showed more signs of stability Wednesday as investors sifted through new economic data and found little reason to resume last week’s heavy selling pace.

The stock indexes wavered in a narrow range, reacting little to comments from Chicago Fed President Michael Moskow that inflation remains stubborn and that interest rate increases might be needed to contain costs. The stock market was similarly unimpressed by data showing a weaker jobs picture and sluggishness in some areas of the country.

Investors in the past week have harbored concerns about a global economic slowdown and have been looking at data to try to determine whether the U.S. economy is still capable of pulling off a soft landing.

In late trading, after drifting higher for most of the afternoon, stocks turned lower again, unable to build on the rally made a day earlier.

Tuesday’s advance was strong — the Dow Jones industrials made up about 26 percent of the losses they suffered in the previous week — but it left investors wondering whether recent volatility that had been absent the markets in recent months would subside long enough to allow Wall Street to build some consensus about where stocks were headed.

Wednesday’s trading, though, was reassuring. Volume levels were more typical of everyday trading than the big numbers Wall Street posted for much of the last week.

“The market is stabilizing after the storm of last week. That’s real progress. It’s extremely welcome. It allows us to restore investor confidence,” said Hugh Johnson, chairman and chief investment officer of Johnson Illington Advisors.

According to preliminary calculations, the Dow Jones industrial average fell 15.14, or 0.12 percent, to 12,192.45. The Dow traded within a 78-point range Wednesday, a much narrower band than in recent sessions.

Broader stock indicators also edged lower. The Standard & Poor’s 500 index fell 3.44, or 0.25 percent, to 1,391.97, and the Nasdaq composite index declined 10.50, or 0.44 percent, to 2,374.64.

Bonds got a lift from the Federal Reserve survey, which said most parts of the country saw modest economic growth in the past month, but many areas saw slowing. The yield on the benchmark 10-year Treasury note fell to 4.50 percent from 4.53 percent late Tuesday.

The dollar was mixed against other currencies, while gold prices rose.

Light, sweet crude rose $1.13 to settle at $61.82 a barrel on the New York Mercantile Exchange after weekly domestic inventory data showed a surprise draw on stocks. The energy market rally drove up stocks of oil companies; Chevron Corp. rose 66 cents to $68.33; Exxon Mobil Corp. rose 64 cents to $71.64; and ConocoPhillips climbed $1.34, or 2 percent, to $67.16.

Overseas markets, which have influenced U.S. trading over the past week, finished mixed and contributed to Wall Street’s uncertainty.

Wall Street also found little inspiration from the Fed’s survey, and shrugged off the ADP National Employment Report, which found private sector employment rose by 57,000 jobs in February, the weakest reading since July 2003. The findings arrived before Labor Department’s employment report Friday, which investors will be closely watching to help gauge the health of the U.S. economy’s lifeblood: its consumers.

Overall, though, there’s no sense of panic in the markets, especially given Wednesday’s mild trading.

“I think stocks have seen the bulk of the declines. I think we will in the next couple of months or so be testing highs,” said Steven Goldman, chief market strategist at Weeden & Co.

In corporate news, CV Therapeutics Inc. fell $2.92, or 24 percent, to $9.38 after the drug maker said its only approved drug failed to show adequate improvement over a placebo at treating heart disease.

Friendly Ice Cream Corp. jumped $1.95, or 16 percent, to $13.79 after the restaurant chain said it would consider putting itself up for sale and that it turned a profit in the fourth quarter.

Saks Inc.’s same-store sales — or sales at stores open at least a year — jumped 24.7 percent in February as the department store chain saw higher sales of full-price merchandise. The stock rose $1.08, or 5.8 percent, to $19.82.

BJ’s Wholesale Club Inc. rose 63 cents, or 2 percent, to $31.53 after the wholesale store chain’s fiscal fourth-quarter profit fell 77 percent amid restructuring costs. Results were stronger than expected.

Conseco Inc., the life and health insurer, fell 91 cents, or 4.6 percent, to $18.75, after it swung to a fourth-quarter loss amid higher expenses. The company also said it won’t offer financial forecasts until it irons out problems in its business.

Advancing issues and decliners were virtually equal on the New York Stock Exchange, where volume came to 1.71 billion shares, down from 1.83 billion Tuesday.

The Russell 2000 index of smaller companies fell 2.98, or 0.38 percent, to 775.90.

Overseas, Japan’s Nikkei stock average closed down 0.47 percent, Hong Kong’s Hang Seng index fell 0.73 percent, the Shanghai Composite Index, which helped trigger last week’s selloff when it fell nearly 9 percent in single session, rose 1.99 percent. Britain’s FTSE 100 closed up 0.29 percent, Germany’s DAX index added 0.34 percent, and France’s CAC-40 advanced 0.33 percent.